Search
for
Sort by
Research 871–900 of 1000+
- Mammalian-specific ectodermal enhancers control the expression of <i>Hoxc</i> genes in developing nails and hair follicles
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5
- Mice lacking the epidermal retinol dehydrogenases SDR16C5 and SDR16C6 display accelerated hair growth and enlarged meibomian glands
- Molecular Background of Pi Deficiency-Induced Root Hair Growth in Brassica carinata – A Fasciclin-Like Arabinogalactan Protein Is Involved
- Pathological Mechanisms Involved in Epidermolysis Bullosa Simplex: Current Knowledge and Therapeutic Perspectives
- Past, Present and Future Perspectives of Forensic Genetics
- Synthetically programmed antioxidant delivery by a domesticated skin commensal
- Celsr1 and Celsr2 exhibit distinct adhesive interactions and contributions to planar cell polarity
- Gender-Difference in Hair Length as Revealed by Crispr-Based Production of Long-Haired Mice with Dysfunctional FGF5 Mutations
- Transcriptional regulation of the thymus master regulator <i>Foxn1</i>
- Prefrontal 5α-reductase 2 mediates male-specific acute stress response
- Wnt/β-Catenin Signaling Stabilizes Hemidesmosomes in Keratinocytes
- Mandibulofacial dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric effects on ligand binding
- KLHL24-Mediated Hair Follicle Stem Cells Structural Disruption Causes Alopecia
- Highlights of Gene and Cell Therapy for Epidermolysis Bullosa and Ichthyosis
- Application of stem cells in regeneration medicine
- Research Techniques Made Simple: Zebrafish Models for Human Dermatologic Disease
- Regulatory T cell dysfunction and immunotherapeutic breakthroughs in type 1 diabetes
- Structural and epistatic regulatory variants cause hallmark white spotting in cattle
- Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- Advanced medical treatments for hair loss
- The GPR30 agonist G-1 promotes hair growth via Wnt/Hedgehog signaling in mice
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Generation of the Krt24-CreERT2 Mouse Line Targeting Outer Bulge Hair Follicle Cells